Comparison of quality of life, depression and fatigue in patients with psoriasis and psoriatic arthritis

Abstract

Psoriatic arthritis (PsA) is a chronic inflammatory multisystemic disease. Limitations due to skin and joint involvement of the patients; can lead to negativie suffix in emotional state, social and physical activities. The aim of this study is to investigate the effects of parameters such as skin joint involvement and disease severity on factors such as fatigue, quality of life, depression, etc. in psoriasis and PsA patients. Thirty-four psoriasis and 48 PsA patients matched with each other in terms of age, sex, and other factors were included in the study. Disease severity was measured by Psoriasis Area Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Disease Activity in Psoriatic Arthritis (DAPSA) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) scores. In order to determine the depression status, quality of life and fatigue levels of the patients, respectively; Beck Depression Inventory (BDI), Health Assessment Questionnaire (HAQ) and Functional Assessment of Chronic Illness Therapy - fatigue scale (FACIT) scores were used. SPSS 17 for statistical evaluation (SPSS Inc. Released 2007. SPSS for Windows, Version 17.0. Chicago, SPSS Inc.) software package was used for analyses. Written informed consent was obtained from all patients who were enrolled to the study. PsA patients were found to have worse quality of life scores than psoriasis patients who were similar in terms of age, gender and other demographic characteristics. (0.22±0.36-0-0.48±0.52 p=0.017 respectively). There was a strong correlation between DAPSA scores and HAQ scores of the cases in the PsA group (r:0 ,615 p<0.05). Likewise, disease activity measured by DAPSA was found to have moderate correlation with FACIT score, and weak but statistically significant correlation with BDI score. (r: -0.578 p<0.05 and r:0.346 p<0.001, respectively). No correlation was found between NAPSI-PASI scores and HAQ, BDI - FACIT scores in both the psoriasis and PsA groups. Both psoriasis and PsA affect the quality of life, and our findings suggest that this effect is more pronounced in PsA patients. Our study supports that; the disease severity in PsA patients is related to depression, bad quality of life and fatigue level.

Keywords

• psoriasis
• arthritis
• disease activity
• inflammation

References

1. 1. Ali Tahsin Güneş. Psoriyazisin Tarihçesi ve Epidemiyolojisi. Turkiye Klinikleri J Int Med Sci, 2005. 1(13): 1-4.
2. 2. Kundakci N, Türsen U, Babiker M,Gürgey E. The evaluation of the sociodemographic and clinical features of Turkish psoriasis patients. Int J Dermatol, 2002. 41(4): 220-4.
3. 3. Ritchlin C.T.Pathogenesis of psoriatic arthritis. Curr Opin Rheumatol, 2005. 17(4): 406-12.
4. 4. Gelfand J.M.,Gladman D, Mease P, Smith N,Margolis D, Nijsten T et al. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol, 2005. 53(4): 573.
5. 5. Hamide KART-KÖSEOĞLU, Psöriyatik Artrit. Turkiye Klinikleri J Immunol Rheumatol; 2004. 4(1): 44-53.
6. 6. Erdem HR., Psöriatik artritin klinik özellikleri. Turkish J Rheum 2000; 15: 31-38.
7. 7. Vahide Baysal Akkaya. Psoriyazisde Tanı ve Ayırıcı Tanı. Turkiye Klinikleri J Int Med Sci. 2005; 1(13): 62-67.
8. 8. Özel S, Ünal B, Koca I. Psöriazis Vulgariste Psöriatik Artrit görülme sıklığı. Ege Fiziksel Tıp ve Rehabilitasyon Dergisi 1997. 3(4): 259- 261.

9. 9. Karaoğlan B, Gül O, Koca İ, Karabay Y. Psoriazis Vulgariste Psoriatik Artrit insidansı, hastalarda klinik ve laboratuvar bulgular. Romatol Tıb Rehab 1992; 3(10): 10-4.
10. 10. Saraç G, Kapıcıoglu Y. Psoriasisin Etyopatogenezi. Dermatoz; 2015. 6(1).
11. 11. Çayakar A. Sedimantasyon & CRP - Geçmişten Geleceğe. Ege Tıp Bilimleri Dergisi; 2019. 2(2): 85-96.
12. 12. Krueger, G.Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001; 137(3): 280-4.
13. 13. Rosen CF,Mussani F, Chandran V, Eder L, Thavaneswaran A, Gladman D. Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone. Rheumatology (Oxford) 2012;51(3): 571-6.
14. 14. Aletaha D, Alasti F, Smolen J S. Disease activity states of the DAPSA, a psoriatic arthritis specific instrument, are valid against functional status and structural progression. Ann Rheum Dis 2017;76(2): 418-421.
15. 15. Bilaç C, Şahin MT, Öztürkcan S. Disease severity scoring systems in dermatology. Turkderm 2016; 50(2):42-53.
16. 16. Cassell SE, Bieber J, Rich P, Tutuncu Z,Lee SJ,Kalunian KC et al., The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis. The Journal of Rheumatology 2007 ;34(1): 123-129.
17. 17. Wong PC,Leung Y-Y, Li EK, Tam L-S. Measuring disease activity in psoriatic arthritis. Int J Rheumatol, 2012; 2012: 839425.
18. 18. Kucukdeveci A.A., Sahin H, Ataman S, Griffiths B, Tennant A. Issues in cross-cultural validity: example from the adaptation, reliability, and validity testing of a Turkish version of the Stanford Health Assessment Questionnaire. Arthritis Rheum 2004; 51(1): 14-9.
19. 19. Ozcan E, Yılmaz Ö, Tutoğlu A, Bodur H., Validity and reliability of the Turkish version of the Health Assessment Questionnaire for the Spondyloarthropathies. Rheumatol Int 2012; 32(6): 1563-8.
20. 20. Hisli N. Beck Depresyon Envanterinin üniversite öğrencileri için geçerliği, güvenirliği. Psikoloji dergisi 1989; 7(23): 3-13.
21. 21. Webster K., Cella D, Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes 2003; (1): 79.
22. 22. Bhosle MJ,Kulkarni A, Feldman S,Balkrishnan R. Quality of life in patients with psoriasis. Health Qual Life Outcomes 2006;4: 35.
23. 23. Tezel N.,Tasdelen O, Bodur H, Gül U, Çakmaj S, Oguz I et al., Is the health-related quality of life and functional status of patients with psoriatic arthritis worse than that of patients with psoriasis alone? Int J Rheum Dis 2015; 18(1): 63-9.
24. 24. Brodszky V, Pentek M,Balint PV, Geher P, Hadju O, Hodinka L et al. Comparison of the Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire, the functional status (HAQ) and utility (EQ-5D) measures in psoriatic arthritis: results from a cross-sectional survey. Scand J Rheumatol 2010; 39(4): 303-9.
25. 25. Lundberg L.,Johannesson M, Silverdahl M,Hermasson C, Lindberg M , Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity. Acta Derm Venereol 2000; 80(6): 430-4.
26. 26. Fortune DG, Main CJ, O'Sullivan TM, Griffiths C E. Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress. Br J Dermatol 1997; 137(5): 755-60.
27. 27. Skevington SM,Bradshaw J,Hepplewhite A, Dawkes K, Lovell CR. How does psoriasis affect quality of life? Assessing an Ingram-regimen outpatient programme and validating the WHOQOL-100. Br J Dermatol 2006; 154(4). 680-91.
28. 28. Ruschenschmidt C,Somberg B, Haussler G, Lohmann J. Comparison of patients with psoriasis vulgaris vs. psoriatic arthritis with regard to the reported quality of life. Rehabilitation 2008; 47(6): 343-9.
29. 29. Lee YW, Park EJ, Kwon IH ,Kwang HK, Kwang JK. Impact of Psoriasis on Quality of Life: Relationship between Clinical Response to Therapy and Change in Health-related Quality of Life. Ann Dermatol 2010; 22(4): 389-96.
30. 30. Lewinson RT, Vallerand I , Lowerison M, Parsons L, Frolkis A,Kaplan G et al., Depression Is Associated with an Increased Risk of Psoriatic Arthritis among Patients with Psoriasis: A Population-Based Study. J Invest Dermatol 2017; 137(4): 828-835.
31. 31. McDonough E, Ayearst R, Eder L, Chandran V, Rosen C, Thavaneswaran A et al. Depression and anxiety in psoriatic disease: prevalence and associated factors. J Rheumatol 2014; 41(5): 887-96.
32. 32. Çayakar A. Halsizlik ve Yorgunluğa Klinik Yaklaşım. Ege Tıp Bilimleri Dergisi 2019; 2(3): 168-78.
33. 33. Karshikoff B, Sundelin T, Lasselin J, Role of Inflammation in Human Fatigue: Relevance of Multidimensional Assessments and Potential Neuronal Mechanisms. Front Immunol 2017; 8: 21.